127 related articles for article (PubMed ID: 6939755)
1. Recurrent infection in glycogenosis type Ib: abnormal neutrophil motility related to impaired redistribution of adhesion sites.
Anderson DC; Mace ML; Brinkley BR; Martin RR; Smith CW
J Infect Dis; 1981 Mar; 143(3):447-59. PubMed ID: 6939755
[TBL] [Abstract][Full Text] [Related]
2. Abnormal mobility of neonatal polymorphonuclear leukocytes. Relationship to impaired redistribution of surface adhesion sites by chemotactic factor or colchicine.
Anderson DC; Hughes BJ; Smith CW
J Clin Invest; 1981 Oct; 68(4):863-74. PubMed ID: 7287906
[TBL] [Abstract][Full Text] [Related]
3. Motility and adhesiveness in human neutrophils. Redistribution of chemotactic factor-induced adhesion sites.
Smith CW; Hollers JC
J Clin Invest; 1980 Apr; 65(4):804-12. PubMed ID: 7358846
[TBL] [Abstract][Full Text] [Related]
4. Impaired chemotaxis and neutrophil (polymorphonuclear leukocyte) function in glycogenosis type IB.
Koven NL; Clark MM; Cody CS; Stanley CA; Baker L; Douglas SD
Pediatr Res; 1986 May; 20(5):438-42. PubMed ID: 3459131
[TBL] [Abstract][Full Text] [Related]
5. Shape, motility and locomotor responses of neutrophil granulocytes.
Keller HU
Agents Actions Suppl; 1983; 12():54-72. PubMed ID: 6340442
[TBL] [Abstract][Full Text] [Related]
6. Defective neutrophil chemotaxis resulting from thermal injury: restoration of directed migration by increasing Boyden chamber filter pore size.
Stein MD; Stevens JM; Herndon DN
Clin Immunol Immunopathol; 1983 May; 27(2):234-9. PubMed ID: 6872354
[TBL] [Abstract][Full Text] [Related]
7. Neutrophil-endothelial cell interactions. Modulation of neutrophil adhesiveness induced by complement fragments C5a and C5a des arg and formyl-methionyl-leucyl-phenylalanine in vitro.
Tonnesen MG; Smedly LA; Henson PM
J Clin Invest; 1984 Nov; 74(5):1581-92. PubMed ID: 6501563
[TBL] [Abstract][Full Text] [Related]
8. Receptor-directed inhibition of chemotactic factor-induced neutrophil hyperactivity by pyrazolon derivatives. Definition of a chemotactic peptide antagonist.
Dahinden C; Fehr J
J Clin Invest; 1980 Nov; 66(5):884-91. PubMed ID: 7430350
[TBL] [Abstract][Full Text] [Related]
9. Motility, cell shape, and locomotion of neutrophil granulocytes.
Keller HU
Cell Motil; 1983; 3(1):47-60. PubMed ID: 6850811
[TBL] [Abstract][Full Text] [Related]
10. A new procedure to analyse the role of adhesion to solid substrata and of motility in chemokinesis of neutrophil granulocytes.
Keller HU; Cottier H
Prog Clin Biol Res; 1982; 85 Pt B():415-23. PubMed ID: 6181523
[TBL] [Abstract][Full Text] [Related]
11. The effects of chemotactic factors on the adhesiveness of rabbit neutrophil granulocytes.
Smith RP; Lackie JM; Wilkinson PC
Exp Cell Res; 1979 Aug; 122(1):169-77. PubMed ID: 477754
[No Abstract] [Full Text] [Related]
12. Neutropenia and impaired neutrophil function in glycogenosis type Ib.
Di Rocco M; Borrone C; Dallegri F; Frumento G; Patrone F
J Inherit Metab Dis; 1984; 7(4):151-4. PubMed ID: 6098781
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo effects of granulocyte colony-stimulating factor on neutrophils in glycogen storage disease type 1B: granulocyte colony-stimulating factor therapy corrects the neutropenia and the defects in respiratory burst activity and Ca2+ mobilization.
McCawley LJ; Korchak HM; Douglas SD; Campbell DE; Thornton PS; Stanley CA; Baker L; Kilpatrick L
Pediatr Res; 1994 Jan; 35(1):84-90. PubMed ID: 7510873
[TBL] [Abstract][Full Text] [Related]
14. Impaired neutrophil killing in a patient with defective degranulation of myeloperoxidase.
Edwards SW; Hart CA; Davies JM; Pattison J; Hughes V; Sills JA
J Clin Lab Immunol; 1988 Apr; 25(4):201-6. PubMed ID: 2845090
[TBL] [Abstract][Full Text] [Related]
15. Phagocytosis-induced modulation of human neutrophil chemotaxis receptors.
Lane TA; Lamkin GC; Windle BE
Blood; 1981 Aug; 58(2):228-36. PubMed ID: 6264995
[No Abstract] [Full Text] [Related]
16. Neutrophil dysfunction in sepsis. II. Evidence for the role of complement activation products in cellular deactivation.
Solomkin JS; Jenkins MK; Nelson RD; Chenoweth D; Simmons RL
Surgery; 1981 Aug; 90(2):319-27. PubMed ID: 7256544
[TBL] [Abstract][Full Text] [Related]
17. Chemotactic deactivation of human neutrophils: relationship to loss of cytotaxin receptor function and temporal nature of the phenomenon.
Nelson RD; Fiegel VD; Herron MJ; Simmons RL
J Reticuloendothel Soc; 1980 Sep; 28(3):285-94. PubMed ID: 7411541
[No Abstract] [Full Text] [Related]
18. A monoclonal antibody-inhibiting FMLP-induced chemotaxis of human neutrophils.
Cotter TG; Keeling PJ; Henson PM
J Immunol; 1981 Dec; 127(6):2241-5. PubMed ID: 7053244
[TBL] [Abstract][Full Text] [Related]
19. Comparison of neutrophil chemotactic response in diabetic patients with mild and severe periodontal disease.
Manouchehr-Pour M; Spagnuolo PJ; Rodman HM; Bissada NF
J Periodontol; 1981 Aug; 52(8):410-5. PubMed ID: 7021793
[No Abstract] [Full Text] [Related]
20. Effects of vitamin K on human neutrophil function.
Gallin JI; Seligmann BE; Cramer EB; Schiffmann E; Fletcher MP
J Immunol; 1982 Mar; 128(3):1399-408. PubMed ID: 6276468
[No Abstract] [Full Text] [Related]
[Next] [New Search]
